G. Retsch-Bogart, A. Quittner, R. Gibson
May 1, 2009
Citations
15
Influential Citations
273
Citations
Quality indicators
Journal
Chest
Abstract
BACKGROUND
We assessed the short-term efficacy and safety of aztreonam lysine for inhalation (AZLI [an aerosolized monobactam antibiotic]) in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA) airway infection.
METHODS
In this randomized, double-blind, placebo-controlled, international study (AIR-CF1 trial; June 2005 to April 2007), patients (n = 164; >or= 6 years of age) with FEV(1) >or= 25% and